Cargando…

ERK1/2 Activity Is Critical for the Outcome of Ischemic Stroke

Ischemic disorders are the leading cause of death worldwide. The extracellular signal-regulated kinases 1 and 2 (ERK1/2) are thought to affect the outcome of ischemic stroke. However, it is under debate whether activation or inhibition of ERK1/2 is beneficial. In this study, we report that the ubiqu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schanbacher, Constanze, Bieber, Michael, Reinders, Yvonne, Cherpokova, Deya, Teichert, Christina, Nieswandt, Bernhard, Sickmann, Albert, Kleinschnitz, Christoph, Langhauser, Friederike, Lorenz, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776221/ https://www.ncbi.nlm.nih.gov/pubmed/35054890 http://dx.doi.org/10.3390/ijms23020706

Ejemplares similares

B cells do not have a major pathophysiologic role in acute ischemic stroke in mice
por: Schuhmann, Michael K., et al.
Publicado: (2017)

Blocking of platelet glycoprotein receptor Ib reduces “thrombo-inflammation” in mice with acute ischemic stroke
por: Schuhmann, Michael K., et al.
Publicado: (2017)

Description of a Novel Phosphodiesterase (PDE)-3 Inhibitor Protecting Mice From Ischemic Stroke Independent From Platelet Function
por: Bieber, Michael, et al.
Publicado: (2019)

Dimethyl Fumarate Attenuates Lymphocyte Infiltration and Reduces Infarct Size in Experimental Stroke
por: Schuhmann, Michael K., et al.
Publicado: (2023)

CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke
por: Schuhmann, Michael K, et al.
Publicado: (2015)

Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation
por: Langhauser, Friedericke, et al.
Publicado: (2013)

Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling
por: Schanbacher, Constanze, et al.
Publicado: (2023)

The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction
por: Varga-Szabo, David, et al.
Publicado: (2008)

Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
por: Tomasovic, Angela, et al.
Publicado: (2020)

Animal models of ischemic stroke and their application in clinical research
por: Fluri, Felix, et al.
Publicado: (2015)

A systems biology approach to cGMP suggests a prominent role for sGC in stroke: Validation by mechanism-based activation of apo-sGC in non-steal dosing coveys neuroprotection and increased survival
por: Casas, Ana I, et al.
Publicado: (2015)

The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro
por: Merches, Katja, et al.
Publicado: (2022)

Glatiramer acetate does not protect from acute ischemic stroke in mice
por: Kraft, Peter, et al.
Publicado: (2014)

Next-generation antithrombotics in ischemic stroke: preclinical perspective on ‘bleeding-free antithrombosis'
por: Kraft, Peter, et al.
Publicado: (2012)

Effects of Extracellular Vesicles from Osteogenic Differentiated Human BMSCs on Osteogenic and Adipogenic Differentiation Capacity of Naïve Human BMSCs
por: Wang, Chenglong, et al.
Publicado: (2022)

Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke
por: Schuhmann, Michael K., et al.
Publicado: (2016)

Proteomic analysis of cathepsin B and L-deficient mouse brain lysosomes
por: Stahl, Sonja, et al.
Publicado: (2007)

Von Willebrand Factor Regulation in Patients with Acute and Chronic Cerebrovascular Disease: A Pilot, Case–Control Study
por: Kraft, Peter, et al.
Publicado: (2014)

Targeting Platelet GPVI Plus rt-PA Administration but Not α2β1-Mediated Collagen Binding Protects against Ischemic Brain Damage in Mice
por: Schuhmann, Michael K., et al.
Publicado: (2019)

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
por: Kraft, Peter, et al.
Publicado: (2010)

Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity
por: Hesse, Julia, et al.
Publicado: (2021)

C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammation
por: Albert-Weissenberger, Christiane, et al.
Publicado: (2014)

Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse platelets
por: Scheller, Inga, et al.
Publicado: (2020)

Targeting coagulation factor XII as a novel therapeutic option in brain trauma
por: Hopp, Sarah, et al.
Publicado: (2016)

A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation
por: Kleikers, Pamela WM., et al.
Publicado: (2015)

The STRIPAK signaling complex regulates dephosphorylation of GUL1, an RNA-binding protein that shuttles on endosomes
por: Stein, Valentina, et al.
Publicado: (2020)

How to Steer and Control ERK and the ERK Signaling Cascade Exemplified by Looking at Cardiac Insufficiency
por: Breitenbach, Tim, et al.
Publicado: (2019)

COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke
por: Kraft, Peter, et al.
Publicado: (2010)

A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection
por: Langhauser, Friederike, et al.
Publicado: (2018)

Sustained Reperfusion after Blockade of Glycoprotein-Receptor-Ib in Focal Cerebral Ischemia: An MRI Study at 17.6 Tesla
por: Pham, Mirko, et al.
Publicado: (2011)

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
por: Kleinschnitz, Christoph, et al.
Publicado: (2006)

Stroke‐induced chronic systolic dysfunction driven by sympathetic overactivity
por: Bieber, Michael, et al.
Publicado: (2017)

Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center
por: Chae, Woon Hyung, et al.
Publicado: (2023)

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
por: Diener, Hans-Christoph, et al.
Publicado: (2016)

Peptidylarginine deiminase 4 promotes age-related organ fibrosis
por: Martinod, Kimberly, et al.
Publicado: (2017)

Sirt3 deficiency does not affect venous thrombosis or NETosis despite mild elevation of intracellular ROS in platelets and neutrophils in mice
por: Hayashi, Hideki, et al.
Publicado: (2017)

Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia
por: David, Christina, et al.
Publicado: (2023)

Feasibility and diagnostic accuracy of point-of-care handheld echocardiography in acute ischemic stroke patients – a pilot study
por: Kraft, Peter, et al.
Publicado: (2017)

Deficiency of Vasodilator-Stimulated Phosphoprotein (VASP) Increases Blood-Brain-Barrier Damage and Edema Formation after Ischemic Stroke in Mice
por: Kraft, Peter, et al.
Publicado: (2010)

Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study
por: Heuschmann, Peter U., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bt6173vu4lvk81tl1hugb5mjjv